knowledge -WSS

knowledge

author：leisure time 2025-10-01 12:11:59 - browse：9

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Large hospital system sues Multiplan for low

WSS

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

The perfect storm of weather conditions that led to the devastating wildfires in Maui

The perfect storm of weather conditions that led to the devastating wildfires in Maui

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

An innovative path out of biotech’s “valley of death”

Newly revealed memo details efforts to keep Trump in power following election loss

leisure time

knowledge

focus

The high cost of giving birth even with insurance

Covid's long

Guidelines to prevent youth baseball injuries need more muscle

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Walensky prepares to leave CDC — and Congress — behind

GOP presidential candidates start declaring their loyalty

Hepatitis C has a cure — but many Americans still lack access to it

J&J lung cancer data amount to new salvo against AstraZeneca

Walensky prepares to leave CDC — and Congress — behind

Newly revealed memo details efforts to keep Trump in power following election loss

Wikipedia

Study on Amgen’s bispecific immunotherapy produces positive data

Faced with fears of OxyContin misuse, sales reps touted its safety

Timeline: Special counsel's investigation into Trump's handling of classified documents

STAT Readout: Friday, Oct. 20 biotech updates

Is there really a nursing shortage in the U.S.?

STAT Summit: How researchers deal with rejection

leisure time

knowledge

leisure time

knowledge